Table G-15EMDR compared with inactive controls (waitlist, usual care)

Domains Pertaining to Strength of EvidenceMagnitude of EffectStrength of Evidence
Number of Studies; Number of SubjectsRisk of Bias; DesignConsistencyDirectnessPrecisionSummary Effect Size (95% CI)High, Moderate, Low, Insufficient
PTSD Symptom Reduction
4; 117Medium; RCTsInconsistent (I2=70%)DirectImpreciseSMD −1.08 (−1.83 to −0.33); SMD −1.37 (−2.05, −0.69) when only compared with WL (3 trials, N=95)Low
Remission (no longer having symptoms)
0; 0NANANANANAInsufficient
Loss of Diagnosis
3; 95Medium; RCTsConsistent (I2=27%)DirectPreciseRD 0.64 (0.46 to 0.81); NNT 1.56Moderate
Prevention/reduction of comorbid depression
4; 117Medium; RCTsConsistent (I2=0%)DirectPreciseSMD −1.13 (−1.52 to −0.74)Moderate
Prevention/reduction of comorbid anxiety: mean change from baseline in STAI
3; 93Medium; RCTsInconsistentDirectImpreciseNo statistically significant difference: WMD −11.08 (−23.06 to 0.90)Insufficient
Quality of Life
0; 0NANANANANAInsufficient
Disability/functional impairment
0; 0NANANANANAInsufficient
Return to work or return to active duty
0; 0NANANANANAInsufficient

Abbreviations: CI = confidence interval; EMDR = eye movement desensitization and reprocessing; NA = not applicable; PTSD = post-traumatic stress disorder; RCT = randomized controlled trial; RD = risk difference; SMD = Standardized mean difference; STAI = State Trait Anxiety Inventory; WMD = weighted mean difference

From: Appendix G, Strength of Evidence

Cover of Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD)
Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD) [Internet].
Comparative Effectiveness Reviews, No. 92.
Jonas DE, Cusack K, Forneris CA, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.